Alpine Immune Sciences (ALPN) Reports Q2 Loss of $0.53/sh

Alpine Immune Sciences (NASDAQ: ALPN) reported Q2 EPS of ($0.53), versus ($0.64) reported last year. Revenue for the quarter came in at $10.44 million, versus $12.72 million reported last year.

For earnings history and earnings-related data on Alpine Immune Sciences (ALPN) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Xylem names Andrea van der Berg as CFO, effective Sept. 2026
• Benchmark Reiterates Buy Rating on H World Group Ltd. (HTHT) Following Q2 Print